Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 11
2004 16
2005 7
2006 5
2007 9
2008 5
2009 9
2010 8
2011 7
2012 10
2013 11
2014 15
2015 11
2016 16
2017 16
2018 14
2019 18
2020 11
2021 15
2022 10
2023 10
2024 12
2025 8
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
The prevalence and long-term response to calcium channel blockers in patients with pulmonary arterial hypertension and positive vasoreactivity test - results of multicenter national registry (BNP-PL).
Piłka M, Darocha S, Waligóra M, Kopeć G, Florczyk M, Torbicki A, Mularek-Kubzdela T, Smukowska-Gorynia A, Lewicka E, Mroczek E, Chrzanowski Ł, Błaszczak P, Kuśmierczyk B, Ptaszyńska K, Mizia-Stec K, Malinowska E, Peregud-Pogorzelska M, Tomaszewski M, Jacheć W, Skoczylas I, Gąsior Z, Pawlak A, Jaguszewski M, Grześk G, Betkier-Lipińska K, Pruszczyk P, Widejko K, Winowska-Józwa J, Kurzyna M. Piłka M, et al. Among authors: torbicki a. Orphanet J Rare Dis. 2026 Feb 25. doi: 10.1186/s13023-026-04250-4. Online ahead of print. Orphanet J Rare Dis. 2026. PMID: 41742179 Free article.
Impact of Elevated Pulmonary Arterial Wedge Pressure on Safety and Efficacy of Balloon Pulmonary Angioplasty in the Treatment of Chronic Thromboembolic Pulmonary Hypertension.
Szwed P, Kurzyna P, Banaszkiewicz M, Kędzierski P, Łomiak M, Wolański R, Wasilewski M, Florczyk M, Piłka M, Torbicki A, Kurzyna M, Darocha S. Szwed P, et al. Among authors: torbicki a. Chest. 2026 Feb;169(2):498-508. doi: 10.1016/j.chest.2025.10.017. Epub 2025 Oct 19. Chest. 2026. PMID: 41115606 Free article.
Efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension in patients with cancer comorbidity.
Banaszkiewicz M, Szwed P, Darocha S, Kurzyna P, Łomiak M, Tomaszewski M, Florczyk M, Kędzierski P, Piłka M, Kasperowicz K, Wieteska-Miłek M, Torbicki A, Krasiński Z, Kurzyna M. Banaszkiewicz M, et al. Among authors: torbicki a. Kardiol Pol. 2025 Nov 28. doi: 10.33963/v.phj.109876. Online ahead of print. Kardiol Pol. 2025. PMID: 41312714 Free article. No abstract available.
Sex-based differences in patients with acute pulmonary embolism managed by a pulmonary embolism response team: a multicenter, retrospective cohort study.
Procyk G, Kurzyna P, Jasińska-Gniadzik K, Smyk JM, Wasilewski M, Wolański R, Szwed P, Rymaszewska D, Zajkowska D, Wrona K, Darocha S, Banaszkiewicz M, Florczyk M, Zieliński D, Wróbel K, Grabowski M, Opolski G, Torbicki A, Kurzyna M, Gąsecka A, Pietrasik A. Procyk G, et al. Among authors: torbicki a. Adv Med Sci. 2025 Oct;70(2):346-352. doi: 10.1016/j.advms.2025.09.003. Epub 2025 Sep 11. Adv Med Sci. 2025. PMID: 40945606
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.
Mahé I, Carrier M, Mayeur D, Chidiac J, Vicaut E, Falvo N, Sanchez O, Grange C, Monreal M, López-Núñez JJ, Otero-Candelera R, Le Gal G, Yeo E, Righini M, Robert-Ebadi H, Huisman MV, Klok FA, Westerweel P, Agnelli G, Becattini C, Bamias A, Syrigos K, Szmit S, Torbicki A, Verhamme P, Maraveyas A, Cohen AT, Ay C, Chapelle C, Meyer G, Couturaud F, Mismetti P, Girard P, Bertoletti L, Laporte S; API-CAT Investigators. Mahé I, et al. Among authors: torbicki a. N Engl J Med. 2025 Apr 10;392(14):1363-1373. doi: 10.1056/NEJMoa2416112. Epub 2025 Mar 29. N Engl J Med. 2025. PMID: 40162636 Clinical Trial.
Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease.
Krasuski RA, Tobore T, Studer S, Jansa P, Sitbon O, Hoeper MM, Channick R, Gaine S, Lang I, Chin K, Pulido T, Mehta S, Torbicki A, Sastry B, Tang X, McLaughlin V, Reardon LC. Krasuski RA, et al. Among authors: torbicki a. JACC Adv. 2025 Mar;4(3):101626. doi: 10.1016/j.jacadv.2025.101626. Epub 2025 Feb 24. JACC Adv. 2025. PMID: 39999520 Free PMC article.
Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension.
Channick R, Medrek S, Delcroix M, Gaine S, Jansa P, Lang I, McLaughlin V, Mehta S, Pulido T, Sastry B, Souza R, Torbicki A, Zhao C, Strachan P, Agron P, Yen J, Sitbon O. Channick R, et al. Among authors: torbicki a. JHLT Open. 2025 Jan 16;7:100197. doi: 10.1016/j.jhlto.2024.100197. eCollection 2025 Feb. JHLT Open. 2025. PMID: 40144855 Free PMC article.
Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities.
McLaughlin VV, Sitbon O, Chin KM, Galiè N, Hoeper MM, Kiely DG, MacDonald G, Martin N, Mathai SC, Peacock A, Tawakol A, Torbicki A, Vonk Noordegraaf A, Rosenkranz S. McLaughlin VV, et al. Among authors: torbicki a. Eur J Heart Fail. 2024 Nov;26(11):2379-2391. doi: 10.1002/ejhf.3319. Epub 2024 Jul 5. Eur J Heart Fail. 2024. PMID: 38966990 Free PMC article. Clinical Trial.
239 results